Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Preemption Cases Expected To Stay On Top Of Legal Calendar In 2008

Executive Summary

As 2007 came to an end, lawyers, judges and others involved in pharmaceutical litigation had just one word on their minds: preemption

You may also be interested in...



Supreme Court Considers Whether Federal Law Blocks State Drug Tort Claims

As the U.S. Supreme Court took up the first case to address whether federal law preempts state personal injury suits against drug manufacturers, two justices appeared to openly favor preemption

Supreme Court Considers Whether Federal Law Blocks State Drug Tort Claims

As the U.S. Supreme Court took up the first case to address whether federal law preempts state personal injury suits against drug manufacturers, two justices appeared to openly favor preemption

FDA Preemption: Agency’s Proposed Labeling Rule Riles Plaintiffs’ Bar

FDA's proposal to restrict when companies can revise product labeling without first getting agency approval drew a sharp reaction from lawyers involved in product liability litigation

Related Content

UsernamePublicRestriction

Register

OM010563

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel